Immunity in maintenance immunosuppression with and without cyclosporine in long-term kidney transplant recipients.
Yamashita
M
M
Department of Nephrology, Toho University, School of Medicine, Tokyo, Japan.
Aikawa
A
A
D001379:Azathioprine / Q000627:therapeutic use; D002478:Cells, Cultured; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000494:pharmacology; D016030:Kidney Transplantation / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects; D007959:Lymphocyte Culture Test, Mixed; D016131:Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D008775:Methylprednisolone / Q000627:therapeutic use; D015375:Receptors, Interleukin-2 / Q000097:blood; D011994:Recombinant Proteins / Q000627:therapeutic use; D012263:Ribonucleosides / Q000627:therapeutic use; D017741:Survivors; D013997:Time Factors
D007166:Immunosuppressive Agents; D007376:Interleukin-2; D015375:Receptors, Interleukin-2; D011994:Recombinant Proteins; D012263:Ribonucleosides; C010052:mizoribine; D016572:Cyclosporine; D001379:Azathioprine; D008775:Methylprednisolone